Follitropin was determined in the sera of 645 probands, and lutropin in the sera of 649 probands between the ages of 5 days and 18 years (neonates, infants, children and adolescents), using microparticleenzyme-immunoassays (MEIA) on the IMx from Abbott Laboratories. The proband collective was divided into 9 age groups and each group into males and females. In accordance with the recommendations of the International Federation of Clinical Chemistry, the 95% scatter range was taken as the reference range. In some age groups, the ranges for individual hormones showed a significant sex difference. Age groups without significant sex differences were combined and evaluated statistically as a single group. Only a few reference groups showed a normal Gaussian distribution. In addition to the 50th percentile, the 2.5th and 97.5th, or the zero and 95th percentiles were determined for all reference groups. Minimal and maximal values were also determined. The U-test of Mann & Whitney was used to test for significant differences between the individual reference groups. Groups showing no significant differences were combined, and reference ranges were finally calculated for follitropin and lutropin in the serum of healthy neonates, infants, children and adolescents.
_ . 4 , . . , two age-related maxima. During the neonatal period Suspected precocious or delayed maturation of the and in the first 6 months of life, the hypothalamohypothalamo-hypophyseal-gonadal axis in children is hypophyseal-gonadal axis becomes temporarily acan indication for the determination of serum gonad-tive, with relatively high serum gonadotropin concenotropins.
trations (1, 2) . After the first year of life, the hypo- 4 , , r *iT r^ ^-*. female pattern (3, 4) . above the normal range for the age of the subject ^ v ' point to a gonadal origin, whereas low values are The aim Qf ^ investigation was: indicative of a central cause. When the serum concentrations of lutropin and follitropin lie in the lower 1) to determine the reference ranges for follitropin part of the reference range, or display pathologicaEy and lutropin in healthy neonates, infants, children decreased values, further differentiation can be and adolescents; achieved by determination of gonadotropin releasing 2) to test for significant sex differences in the studied hormones.
quantities within the age groups; and Even in childhood, the serum concentrations of go-3) to test for significant differences in the studied nadotropins display typical sex-specific changes, with quantities between the age groups.
Materials and Methods
Follitropin was determined in the sera of 645 subjects, and lutropin in the sera of 649 subjects between the ages.of 5 days and 18 years (neonates, infants, children and adolescents). In the course of routine screening for hypothyreosis venous blood was taken from 5-day-old neonates. For all other probands blood samples were taken after written consent was obtained from their parents, who were informed as to the purpose of the tests. The Ethics Commission of the Medical School of Erfurt gave its agreement for this purpose. The age composition of the proband collective is summarized in table 1. Individuals were included or excluded according to the exclusion criteria of Witt & Trendelenburg (5) , which permit the assembly of a reliable reference sample at a justifiable expense. Only neonates with a birthweight between 2500 and 4000 g and a full term gestation time between 37 and 40 weeks were admitted to the 5-day-old age group. Neonates with hyperbilirubinaemia were excluded, as well as those born to mothers with acute or chronic illnesses. In sexually mature girls, blood was taken during the first 10 days of the follicular phase of a monthly cycle.
Tab. 1. Age composition of the proband collective used for the determination of reference ranges of follitropin and lutropin in neonates, infants, children and adolescents Method sensitivities, determined on the IMx used for the present study, were 0.17 U/l for follitropin, and 0.07 U/l for lutropin.
If the serum concentrations of foliitrppin or lutropin lay below these respective limits, they were treated as equivalent to the value for test sensitivity (4, 6) . Such test results were recorded and identified by a preceding "<".
The follitropin assay was calibrated with WHO-standard 78/549, the lutropin assay with WHO-standard 68/40.
Quality control
For the control of precision from day to day, standards (from Abbott) of low, intermediate and high concentration were in* eluded in each series (7) . As a measure of the relative methodical error, the arithmetic mean (x), standard deviation (s) and the variation coefficient (CV) were calculated from the individual results of these control series. Precision in series was monitored once, using the "B" and "E" calibrators (low and high concentrations) from Abbott. Again, the arithmetic mean (x), standard deviation (s) and the variation coefficient (CV) were calculated from the individual results.
Statistical evaluation of the results
The results were first presented as separate histograms for each age group and for each sex. The type of distribution was determined with the Kolmogorov-Smirnov test. If the resulting probability error was below the stated value of α = 0.05, the distribution was assumed to be normal. If the distribution was not normal, the 2.5th, 50th and 97.5th percentiles were determined for that reference group (8). If the 2.5th percentile lay below the sensitivity of the method, the zero, 50th and 95th percentiles were determined (9).
In each age group, the values of follitropin-.and lutropin were tested for significant differences between the sexes, using the U-test of Mann & Whitney. In the absence of a significant sexrelated difference, males and females were subsequently treated as a single group. The significance of differences between age groups was also tested with the U-test of Mann & Whitney.
The degree of any linear relationship between age and the measured quantities was determined by calculation of the correlation coefficient, r.
Results

Follitropin
Follitropin was determined in the serum of 645 healthy probands (330 males, 315 females). Figure 1 gives an overview of the results for all groups before significance testing. Significant differences between the sexes were found in age groups 2, 3, 4, 5, 6, 7 and 8. All reference groups were tested for significant differences, using the U-test of Mann & Whitney. The new group combinations, formed after significance testing, are shown in table 3. The median value and reference range for serum follitropin were recalculated for each new group combination. Five-day-old neonates did not differ significantly from males in the age range 2 months to 9 years. Since the results for neonates showed a wide scatter, and their 2.5th percentile was lower than the sensitivity of the analytical method, they were, however, treated as a separate group. Similarly, the group of 14 to 15 yearold males showed widely scattered results and was therefore treated separately, although it did not differ significantly from the 4 to 6 year-old females, the 10 to 11 year-old females, or the 12 to 13 year-old males.
Lutropin
Lutropin was determined in the serum of 649 healthy probands (336 males, 313 females). Significant differences between the sexes were found in age groups 1, 2 and 8. The U-test of Mann & Whitney was used to test for significant differences between the reference groups, and where possible groups showing no significant differences were combined. For each group combination made in this way, the median and reference range for serum lutropin were recalculated. An overview of the results is given in table 4 and figure 2.
Correlation analysis
Correlations with proband age were sought for the serum concentrations of follitropin and lutropin. There was a significant correlation (p < 0.001) between the age of the investigated probands (in months) and the concentration of each hormone, i.e. the concentrations of follicle stimulating hormone and luteinizing hormone increased with age (r = 0.5152 and 0.4141, respectively). 
Quality control
Results of the quality control are shown in tables 5 and 6. The variation coefficients within series and between series were all less than 10%. 
Discussion
In addition to the anamnesis and the interpretation of clinical symptoms, the determination of hormone concentrations in serum is extremely important in the diagnosis of pathological endocrine conditions. To enable the correct evaluation of the serum concentration of a hormone, reference ranges must be established.
Modern immunological assays include the classical radioimmunoassay and several sensitive immunometric methods, e. g. MEIA, IFMA, IRMA, FPIA and time-delayed FPIA, the results of which sometimes show considerable disagreement (3, 4, 10, 11) .
In the present study, microparticle enzyme irrim noassays (MEIA) were used. These methods have the advantage that they yield results quiokly, require only a small sample volume, and do not employ radioactive isotopes. Reference ranges for children, determined -with these methods, have not been reported in the literature.
In each group, the type of distribution was determined by the Kolmogorov-Smirnov test. Since the reference values in most age groups were not normally distributed, the reference range was determined by calculating the median value and the 2.5th and 97.5th percentiles, or the zero and 95th percentiles. In accordance with the recommendations of the International Federation of Clinical Chemistry, the 95% scatter range was taken as the reference range (8).
The U-test of Mann & Whitney was used to test for significant differences between the serum hormone concentrations of different age groups. Age groups showing no significant differences with respect to a particular hormone were usually combined and the median value and percentiles recalculated.
To facilitate comparison of the present results with those from the literature (12-14) , the latter are presented in tables 7 and 8.
The reported reference ranges for the serum concentrations of follitropin and lutropin differ from those shown in tables 7 and 8 for the following reasons: 1) different methods were used;
2) the other authors used different age classifications, based partly on the puberty stages of Tanner,
3) the numbers of probands in the age groups of other authors were very small; 4) with the exception of Struckmeyer & Haid (13), the quoted authors gave no exact data on the type of distribution of the reference values.
All the quoted authors reported an increase in serum follitropin with age in both males and females, with rather higher values for females than for males of the same age. They all also detected two age-related maxima in the median or average follitropin values in females. The results of the last two authors (13, 14) suggest that these two follitropin maxima may also occur in males.
Serum lutropin concentrations increased with age in both males and females. All authors found higher median or average serum lutropin values in infant males. In the present study, this difference between males and females was significant in 5-day-old neonates and in infants between the ages of 2 and 12 months. Table 9 shows the reference ranges for each hormone, as determined in the present study.
